Skip to content

Category Archives: Cedars-Sinai Medical Center

Medical Corporations Crossing the Line > Journal’s Article Questions TV Ads for Cypher stent > New England Journal of Medicine > Cordis subsidiary of Johnson & Johnson > Direct-to-consumer advertising DTCA > Percutaneous transluminal coronary angioplasty PTCA > Consumer Health Education > State University of New York > Cedars-Sinai Medical Center

Monday, May 26, 2008

What are the basic regulatory requirements for non-deceptive advertising of medical corporations? Why is there no requirement to report negative side effects to a toll-free number operated by the FDA that is currently required for print prescription drug ads but not for medical devices? Is the device industry campaign trying to perceive an informed, balanced […]

Filed in Non-deceptive advertising of medical devices, Regulatory requirements, Industry marketing campaign, Informed balanced conversation, Patients and physicians, Endovascular resection, Cedars-Sinai Medical Center, Endolumenal therapy, Endovascular aneurysm repair EVAR, Endovascular Therapy, Endovascular repair of abdominal aortic aneurysms EVAR, Pushing stent product, Treatment options for coronary artery disease, TV Ads for Cypher stent, Cordis subsidiary of Johnson & Johnson, Consumer Health Education, State University of New York, New England Journal of Medicine NEJM, Medical Corporations Crossing the Line, Report negative side effects, Required for print prescription drug ads, Direct-to-consumer advertising DTCA, Percutaneous transluminal coronary angioplasty PTCA, Vascular Surgeons, Interventional procedures, Subsidiary of a major stent-graft company, Stent-graft technology under serious scrutiny, Stent Stapler, Stent graft fixation product, Warning letter, Long-term graft performance, Endoluminal Endolumenal Hollow Vessel, Endovascular stent graft, Endovascular stenting, Need for reintervention, Fixation of stent grafts, Stent grafts have a tendency to migrate, Type I endoleaks, Endovascular techniques prone to similar complications, Paraplegia secondary to spinal cord ischaemia, Complication of stent-graft repair, Stent graft migration following endovascular aneurysm r, Aorfix Dacron stent-graft, Endoleaks, Keep the graft in place, GORE EXCLUDER AAA Endoprosthesis, Surgical revision, Ideas For Surgery News | Comments Off

Satiety > Transoral Gastroplasty > NOTES > NOSCAR > Treatment of Morbid Obesity > TOGA™ > Study not yet open for participant recruitment > Primary Outcome Measures > Proportion of subjects with ≥ 25% EWL Excess Weight Loss > Cedars-Sinai Medical Center > Washington University in St. Louis > University of Texas Medical School at Houston > Columbia University Medical Center > Erasme Hospital Brussels

Tuesday, April 22, 2008

IIP > Read on here > http://clinicaltrials.gov…
…The TOGA™ trial is a prospective, multi-center, randomized sham-controlled trial designed to determine the safety and effectiveness of the TOGA System for the treatment of morbid obesity. The study will also determine the effect of the treatment on co-morbidities and quality of life.
Subjects will be blinded to treatment or […]

Filed in no external scars whatsoever, NOTES exploration of the abdomen, NOTES access is safe and feasible, NOTES's going to happen relatively fast, Non-surgical option, Obesity Surgery, No slow down in Obesity epidemic, NOTES procedure offer substantial benefits, no scars to remind of the operation, Diabetes is killing about 73,000 people in the U.S. eac, Overnutrition, Overweight, Nutrition Disorders, Metabolic disorder, Natural orifice surgery appendectomy, Other bariatric weight loss operations cost $25,000 in , LAGB banding costs $17,000 in the USA, Laparoscopic Adjustable Gastric Banding LAGB, nterventional diagnosis, OAS system, Erasme Hospital Brussels, Columbia University Medical Center, University of Texas Medical School at Houston, Body Weight, Signs and Symptoms, Pathological Conditions, Nutritional and Metabolic Diseases, MeSH terms, Washington University in St. Louis, Cedars-Sinai Medical Center, Satiety, NOSCAR research for safe adoption, OAS clinical trial program, Transoral Gastroplasty TOGA, Treatment of Morbid Obesity, Proportion of subjects with 25% EWL Excess Weight Loss, Primary Outcome Measures, Study not yet open for participant recruitment, Metabolic Diseases, Pouch enlargement or dilatation of the gastrojejunostom, International Conference on NOTES, No scar anti reflux procedure, Significantly reduced level of pain and discomfort, No Scar Group SAGES, Risk factor obesity, Body mass index, No CPT code, Potential to replace or augment current techniques, Multi-center trial of a NOTES system, NOTES techniques, Way of the future, NOTES, NOTES & NEWS, No-scar abdominal surgery, Initial applications of NOTES, Incision-less solutions, NOTES fundoplication procedure, Intentionally making gastrotomy for a cholecystectomy, Treatment Of Obesity, Obesity, NoScarSurgeons.com, Patients Who Gain Weight After Bariatric Surgery, Incisionless Natural Orifice Surgery, Morbid obesity, Body mass index of greater than 50, Gastric bypass pouch and stoma reduction, Natural Orifices transgastric endoscopic surgery NOTES, Surgical obesity intervention, Gastrotomy Closure in NOTES, Reduces Size of Stomach Pouch, scar-free surgery, NOTES and hybrid NOTES procedures, Recovery-free surgery, No visible skin scar, Reduced post-operative pain, Incisionless Surgical Technique, Weight Re-gain After Gastric Bypass, No Scar Surgery | Comments (0)